Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterizing the EEG Signature of Fentanyl and Its Association With Drug Liking

NCT06699953 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT06699953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06699953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterizing the EEG Signature of Fentanyl and Its Association With Drug Liking
Lead sponsor
Stanford University
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 4, 2025
Completion date
December 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain activity related to drug liking, brain activity related to opioid administration